MedTrace Logo

Evaluation of the Impact of Transit Troubles in Patients Undergoing Peritoneal Dialysis

NCT04102527 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2022-09-08

No results posted yet for this study

Summary

Patients with Terminal Chronic Kidney Disease undergoing Peritoneal Dialysis (PD) often have pathophysiological factors that promote chronic constipation. It affects the quality of life of Patients undergoing PD in a much greater way than for hemodialysis patients because it causes complications, mechanical and infectious associated with the transmural migration of enteral bacteria, with an impact on patient morbidity and survival of the technique. In addition, it should be noted that PD patients often take potentially constipants treatments such as phosphorus chelators, calcium inhibitors, opiates, iron preparation and antidepressants. Taking these drugs decreases gastric acidity, which is associated with an increased prevalence of peritonitis.

In this context, a significant lack of literature, specifically studying the risk factors for constipation in Terminal Chronic Kidney Disease patients treated with DP and the correlation with mechanical and infectious complications, is improvable.

Conditions

Interventions

OTHER

Questionnaires

Patients have to complete the study questionnaires every 2 months : * Digestive Functional Score of Neurological Patients * Bowel Function Index * Severity score for constipation * Bristol Scale * Constipation assessment scale * Estimate scale of risk of constipation

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    collaborator OTHER

  • Centre Hospitalier de Vichy

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-19
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04102527 on ClinicalTrials.gov